Department of Epidemiology, Colorado School of Public Health, University of Colorado Denver, Aurora, CO 80045, USA.
J Dev Behav Pediatr. 2010 Apr;31(3):181-91. doi: 10.1097/DBP.0b013e3181d5aa6d.
We assessed the prevalence of autism spectrum disorders (ASD) and screening test characteristics in children with Down syndrome.
Eligible children born in a defined geographic area between January 1, 1996, and December 31, 2003, were recruited through a population-based birth defects registry and community outreach, then screened with the modified checklist for autism in toddlers or social communication questionnaire, as appropriate. Screen-positive children and a random sample of screen-negative children underwent developmental evaluation.
We screened 123 children (27.8% of the birth cohort). Mean age was 73.4 months (range, 31-142). Compared to screen-negative children, screen-positive children had similar sociodemographic characteristics but a lower mean developmental quotient (mean difference: 11.0; 95% confidence interval: 4.8-17.3). Weighted prevalences of autistic disorder and total ASD were 6.4% (95% confidence interval [CI]: 2.6%-11.6%) and 18.2% (95% CI: 9.7%-26.8%), respectively. The estimated minimum ASD prevalence, accounting for unscreened children, is 5.1% (95% CI: 3.3%-7.4%). ASD prevalence increased with greater cognitive impairment. Screening test sensitivity was 87.5% (95% CI: 66.6%-97.7%); specificity was 49.9% (95% CI: 37.0%-61.4%).
The prevalence of ASD among children with Down syndrome aged 2 to 11 years is substantially higher than in the general population. The modified checklist for autism in toddlers and social communication questionnaire were highly sensitive in children with Down syndrome but could result in many false positive tests if universal screening were implemented using current algorithms. Research needs include development of specific ASD screening algorithms and improved diagnostic discrimination in children with Down syndrome. Timely identification of these co-occurring diagnoses is essential so appropriate interventions can be provided.
评估唐氏综合征患儿自闭症谱系障碍(ASD)的患病率和筛查测试特征。
通过基于人群的出生缺陷登记处和社区外展,招募 1996 年 1 月 1 日至 2003 年 12 月 31 日期间在某一特定地理区域出生的合格儿童,然后根据需要使用改良婴儿自闭症检查表或社会沟通问卷对其进行筛查。对筛查阳性儿童和随机选择的筛查阴性儿童进行发育评估。
我们共筛查了 123 名儿童(占出生队列的 27.8%)。平均年龄为 73.4 个月(范围 31-142 个月)。与筛查阴性儿童相比,筛查阳性儿童具有相似的社会人口统计学特征,但发育商平均值较低(平均差异:11.0;95%置信区间:4.8-17.3)。自闭症障碍和自闭症谱系障碍的加权患病率分别为 6.4%(95%置信区间:2.6%-11.6%)和 18.2%(95%置信区间:9.7%-26.8%)。考虑到未筛查儿童,估计 ASD 的最低患病率为 5.1%(95%置信区间:3.3%-7.4%)。ASD 患病率随认知障碍程度的增加而增加。筛查测试的灵敏度为 87.5%(95%置信区间:66.6%-97.7%);特异性为 49.9%(95%置信区间:37.0%-61.4%)。
2-11 岁唐氏综合征儿童的 ASD 患病率明显高于普通人群。改良婴儿自闭症检查表和社会沟通问卷在唐氏综合征儿童中具有很高的灵敏度,但如果使用当前算法进行普遍筛查,可能会导致大量假阳性测试。研究需求包括开发特定的 ASD 筛查算法和提高唐氏综合征儿童的诊断区分能力。及时识别这些共存诊断至关重要,以便提供适当的干预措施。